Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Johnson and Johnson
McKesson
Teva
QuintilesIMS

Generated: July 15, 2019

DrugPatentWatch Database Preview

Patent: 8,450,377

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,450,377
Title:1-adamantyl chalcones for the treatment of proliferative disorders
Abstract: The present invention relates to the compounds of the general formula (I), a composition for and a method of treating breast cancer or other proliferative disorders in a subject using a compound of general formula [I], ##STR00001## wherein the substituents are as defined in the specification.
Inventor(s): Anderson; Gloria L. (Atlanta, GA), Kaimari; Tawfeq Abdul-Raheem (Kennesaw, GA)
Assignee:
Application Number:13/224,829
Patent Claims:see list of patent claims

Details for Patent 8,450,377

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Cantor Fitzgerald
McKinsey
Healthtrust
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.